CME Group Inc. Announces Preliminary Results from its 2022 Annual Meeting of Shareholders

Rhea-AI Summary

CME Group (NASDAQ: CME) released preliminary results from its 2022 annual meeting of shareholders held on May 4, 2022. Key outcomes include the election of 15 directors for a one-year term, the ratification of Ernst & Young LLP as the independent auditor, and the approval of several amended stock plans. However, the advisory vote on executive compensation was not approved. Class B-2 shareholders elected two directors, while no quorum was present for Class B-1 and B-3 director elections, leading to holdover directors. Official results will be filed with the SEC.

Positive

• Elected 15 directors for one-year terms, ensuring stable governance.
• Ratified Ernst & Young LLP as the independent auditor for 2022.
• Approved multiple amended stock plans, enhancing employee compensation.

Negative

• Advisory vote on compensation of named executive officers was not approved.
• No quorum in elections for Class B-1 and B-3 directors, leading to holdovers.

CHICAGO, May 4, 2022 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today announced the preliminary shareholder voting results from its 2022 annual meeting. 

At the meeting, shareholders:

• Elected Terrence A. Duffy, Timothy S. Bitsberger, Charles P. Carey, Dennis H. Chookaszian, Bryan T. Durkin, Ana Dutra, Martin J. Gepsman, Larry G. Gerdes, Daniel R. Glickman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Terry L. Savage, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2023; and
• Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2022; and
• Approved the Amended and Restated Omnibus Stock Plan; and
• Approved the Amended and Restated Director Stock Plan; and
• Approved the Amended and Restated Employee Stock Purchase Plan.

The advisory vote on the compensation of named executive officers was not approved.

In addition, the company's Class B-2 shareholders elected Michael G. Dennis and Patrick W. Maloney each for a one-year term expiring in 2023.

There was no quorum in the elections of the Class B-1 directors and the Class B-3 director. As a result, William W. Hobert, Patrick J. Mulchrone and Robert J. Tierney Jr. will holdover as the Class B-1 directors, and Elizabeth A. Cook will holdover as the Class B-3 director.  Each director will continue to serve until his or her successor is duly elected at the 2023 annual meeting.

The official results and voting percentages for each of these proposals will be disclosed in a report to be filed with the Securities and Exchange Commission.

As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals.  The company offers futures and options on futures trading through the CME Globex® platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform.  In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc.  CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc.  All other trademarks are the property of their respective owners.  

CME-G

 

View original content:https://www.prnewswire.com/news-releases/cme-group-inc-announces-preliminary-results-from-its-2022-annual-meeting-of-shareholders-301539966.html

SOURCE CME Group

FAQ

What were the preliminary shareholder voting results for CME on May 4, 2022?

CME announced the election of 15 directors, ratification of Ernst & Young LLP as auditor, and approval of various stock plans, but the advisory vote on executive compensation was not approved.

Who were elected as directors at CME's 2022 annual meeting?

Fifteen directors, including Terrence A. Duffy and Timothy S. Bitsberger, were elected for a one-year term.

What happened with the advisory vote on executive compensation for CME?

The advisory vote on the compensation of named executive officers was not approved during the annual meeting.

What does it mean that there was no quorum for Class B-1 and B-3 director elections at CME?

It means the elections could not be conducted, resulting in holdover directors continuing to serve.